Archives

Industry Meeting Recap: Treatment for Depression and Beyond

May 11 – 13, 2018 marked the Clinical TMS Society Annual Meeting, where 550+ attendees from more than 30 countries came together in Brooklyn, New York to share expert insight and discuss what’s ahead for Transcranial Magnetic Stimulation, or TMS. The two-day conference showcased the practical and the potential of providing TMS as a clinical… Read More

The Neurostar Advance Therapy Outcomes Registry

Dr. W. Scott West co-presented with Greg Harper, VP of Product Development & Operations of NeuroStar, at the 2018 Clinical TMS Society Annual Meeting. We invite you to review our presentation, The Neurostar Advance Therapy Outcomes Registry - On Track to be the Largest Registry of Treatment-Resistant Depression. View/Download Presentation

APA TV: TMS Therapy Combats Depression, NeuroStar Technology Leads the Way

Dr. W. Scott West discusses Transcranial Magnetic Stimulation (TMS) therapy using NeuroStar technology, the #1 TMS choice of doctors for the treatment of depression. Listen to Dr. West, Medical Director of ThriveLogic TMS + NeuroHealth and Nashville NeuroCare Therapy, highlight depression rates, treatment options and why he believes TMS is a proven and safe therapy... Read More

Dr. Scott West and NeuroStar TMS Therapy for Depression – News Channel 4 WSMV

Anti-depressants are the most common way to tackle depression, but they don't work for everyone, and medications often come with side effects. TMS Therapy is rising in popularity as an effective treatment, helping millions of Americans to feel joy again. Dr. W. Scott West shares insight on this proven technology. Click the image below to... Read More

NeuroStar® Advanced Therapy Depression Outcomes Registry Surpasses 500 Patient Milestone

Preliminary results validate real-world outcomes and continue to demonstrate TMS therapy is an important non-medication treatment option for depression MALVERN, Pa., May 22, 2017 /PRNewswire/ — NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), today announced its depression outcomes registry has exceeded 500 patients at approximately 50 treatment facilities in the United… Read More